Publications by authors named "Donald C Moore"

31Publications

Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients.

J Oncol Pharm Pract 2020 Dec 26:1078155220982648. Epub 2020 Dec 26.

Department of Pharmacy, Atrium Health, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
December 2020

Evaluation of a pharmacist-driven rapid infusion rituximab conversion protocol at a multisite cancer center.

J Oncol Pharm Pract 2020 Dec 9:1078155220977898. Epub 2020 Dec 9.

Levine Cancer Institute, Charlotte, NC, USA.

View Article and Find Full Text PDF
December 2020

Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.

J Oncol Pharm Pract 2020 Oct 27:1078155220967440. Epub 2020 Oct 27.

Atrium Health, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
October 2020

Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma.

Ann Hematol 2020 Oct 1. Epub 2020 Oct 1.

Department of Hematology/Oncology, Atrium Health, Levine Cancer Institute, 1656 Riverchase Blvd, Rock Hill, SC, 29732, USA.

View Article and Find Full Text PDF
October 2020

Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab.

Clin Lymphoma Myeloma Leuk 2020 Oct 7;20(10):e777-e781. Epub 2020 Jun 7.

Department of Hematologic Oncology and Blood Disorders, Atrium Health, Levine Cancer Institute, Charlotte, NC.

View Article and Find Full Text PDF
October 2020

Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura.

Am J Health Syst Pharm 2020 07;77(15):1201-1207

Department of Pharmacy, Levine Cancer Institute, Atrium Health, Concord, NC.

View Article and Find Full Text PDF
July 2020

Risk of hepatotoxicity with trastuzumab emtansine in breast cancer patients: a systematic review and meta-analysis.

Ther Adv Drug Saf 2020 21;11:2042098620915058. Epub 2020 Apr 21.

Pharmacist Clinical Coordinator, Hematology/Oncology, Atrium Health, Levine Cancer Institute, 100 Medical Park Drive, Concord, NC 28025, USA.

View Article and Find Full Text PDF
April 2020

Impact of Body Mass Index on the Incidence of Bortezomib-induced Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma.

Clin Lymphoma Myeloma Leuk 2020 03 18;20(3):168-173. Epub 2019 Sep 18.

Atrium Health, Levine Cancer Institute, Rock Hill, SC. Electronic address:

View Article and Find Full Text PDF
March 2020

Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience.

J Thromb Thrombolysis 2020 Apr;49(3):431-440

Division of Hematology/Oncology, University of Virginia Health System, PO Box 800716, Charlottesville, VA, 22908, USA.

View Article and Find Full Text PDF
April 2020

Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.

Ann Pharmacother 2020 04 25;54(4):371-379. Epub 2019 Oct 25.

Atrium Health, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
April 2020

Eltrombopag-Associated Acneiform Rash: A Case Report.

Am J Ther 2019 Sep 17. Epub 2019 Sep 17.

Atrium Health, Levine Cancer Institute, Concord, NC.

View Article and Find Full Text PDF
September 2019

Fostamatinib for the treatment of immune thrombocytopenia in adults.

Am J Health Syst Pharm 2019 May;76(11):789-794

Department of Hematology/Oncology, Atrium Health, Levine Cancer Institute, Rock Hill, SC.

View Article and Find Full Text PDF
May 2019

Neutropenia-Associated Outcomes in Patients With Breast Cancer Receiving Myelosuppressive Chemotherapy With Reduced Doses of Pegfilgrastim.

J Pharm Pract 2020 Dec 27;33(6):779-783. Epub 2019 Mar 27.

Department of Pharmacy, Atrium Health, Levine Cancer Institute, Charlotte, NC, USA.

View Article and Find Full Text PDF
December 2020

Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses.

Leuk Lymphoma 2019 09 8;60(9):2295-2298. Epub 2019 Mar 8.

Department of Hematologic Oncology and Blood Disorders, Atrium Health, Levine Cancer Institute , Charlotte , NC , USA.

View Article and Find Full Text PDF
September 2019

Olaratumab: A New Strategy in the Treatment of Advanced Soft-Tissue Sarcoma.

J Adv Pract Oncol 2018 Mar 1;9(2):235-240. Epub 2018 Mar 1.

Levine Cancer Institute, Atrium Health, Rock Hill, South Carolina; and Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.

View Article and Find Full Text PDF
March 2018

Case series of docetaxel-induced dorsal hand-foot syndrome.

Ther Adv Drug Saf 2018 Aug 21;9(8):495-498. Epub 2018 May 21.

Pharmacist Clinical Coordinator - Oncology, Levine Cancer Institute, Atrium Health, Department of Pharmacy, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA.

View Article and Find Full Text PDF
August 2018

Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting.

Am J Health Syst Pharm 2018 Nov 21;75(22):1824-1830. Epub 2018 Aug 21.

Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC.

View Article and Find Full Text PDF
November 2018

Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma.

J Oncol Pharm Pract 2019 Apr 31;25(3):613-622. Epub 2018 Jul 31.

2 Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article and Find Full Text PDF
April 2019

Case Report of Ipilimumab-Induced Diffuse, Nonnecrotizing Granulomatous Lymphadenitis and Granulomatous Vasculitis.

J Pharm Pract 2018 Apr 21;31(2):227-229. Epub 2017 Mar 21.

3 Department of Pharmacy, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article and Find Full Text PDF
April 2018

Rucaparib: A Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Ovarian Cancer.

J Pharm Pract 2019 Apr 22;32(2):219-224. Epub 2017 Nov 22.

1 Department of Pharmacy, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article and Find Full Text PDF
April 2019

Nilotinib-Induced Ocular Toxicity: A Case Report.

Am J Ther 2018 Sep/Oct;25(5):e570-e571

Oncology, Levine Cancer Institute, Carolinas HealthCare System, Rock Hill, SC.

View Article and Find Full Text PDF
March 2019

Acneiform Rash With Ramucirumab and Paclitaxel in a Patient With Recurrent Esophageal Cancer.

Authors:
Donald C Moore

Am J Ther 2018 Sep/Oct;25(5):e557-e558

Department of Pharmacy, Carolinas HealthCare System, Levine Cancer Institute, Rock Hill, SC.

View Article and Find Full Text PDF
March 2019

Pegfilgrastim-Induced Bone Pain: A Review on Incidence, Risk Factors, and Evidence-Based Management.

Ann Pharmacother 2017 Sep 19;51(9):797-803. Epub 2017 Apr 19.

1 Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article and Find Full Text PDF
September 2017

Necitumumab for the treatment of squamous cell non-small cell lung cancer.

J Oncol Pharm Pract 2018 Jan 2;24(1):37-41. Epub 2016 Dec 2.

2 Department of Pharmacy, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA.

View Article and Find Full Text PDF
January 2018

Cost savings analysis and toxicity audit of a bevacizumab dose rounding policy at a community cancer center.

J Oncol Pharm Pract 2018 Jan 19;24(1):42-46. Epub 2016 Oct 19.

2 Regional Director of Pharmacy, Southeast Health, Department of Pharmacy, Dexter, MO USA.

View Article and Find Full Text PDF
January 2018

Abiraterone-induced rhabdomyolysis: A case report.

J Oncol Pharm Pract 2017 Mar 9;23(2):148-151. Epub 2016 Jul 9.

Southeast Missouri Hospital, Cape Girardeau, MO, USA.

View Article and Find Full Text PDF
March 2017